The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

May 23, 2022

Study Completion Date

March 24, 2023

Conditions
MDC1ASELENON-related Myopathy
Interventions
OTHER

No intervention

This concerns a natural history study; no interventions will be used

Trial Locations (1)

6500 HB

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04478981 - The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2 | Biotech Hunter | Biotech Hunter